Cargando…

Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells

Bisphosphonates, besides being important drugs for the treatment of various bone diseases, could also be used to induce apoptosis in macrophage-like and cancer cells. However, their activity in vivo is limited by a short plasma half-life and rapid uptake within bone. Therefore, several delivery syst...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabatino, Raffaella, Antonelli, Antonella, Battistelli, Serafina, Schwendener, Reto, Magnani, Mauro, Rossi, Luigia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072741/
https://www.ncbi.nlm.nih.gov/pubmed/24968029
http://dx.doi.org/10.1371/journal.pone.0101260
_version_ 1782323015408680960
author Sabatino, Raffaella
Antonelli, Antonella
Battistelli, Serafina
Schwendener, Reto
Magnani, Mauro
Rossi, Luigia
author_facet Sabatino, Raffaella
Antonelli, Antonella
Battistelli, Serafina
Schwendener, Reto
Magnani, Mauro
Rossi, Luigia
author_sort Sabatino, Raffaella
collection PubMed
description Bisphosphonates, besides being important drugs for the treatment of various bone diseases, could also be used to induce apoptosis in macrophage-like and cancer cells. However, their activity in vivo is limited by a short plasma half-life and rapid uptake within bone. Therefore, several delivery systems have been proposed to modify their pharmacokinetic profile and biodistribution. Among these, red blood cells (RBCs) represent one of the most promising biological carriers. The aim of this study was to select the best performing compound among Clodronate, Pamidronate, Ibandronate and Zoledronate in killing macrophages and to investigate RBCs as innovative carrier system to selectively target bisphosphonates to macrophages. To this end, the encapsulation of the selected bisphosphonates in autologous RBCs as well as the effect on macrophages, both in vitro and in vivo were studied. This work shows that, among the tested bisphosphonates, Zoledronate has proven to be the most active molecule. Human and murine RBCs have been successfully loaded with Zoledronate by a procedure of hypotonic dialysis and isotonic resealing, obtaining a dose-dependent drug entrapment with a maximal loading of 7.96±2.03, 6.95±3.9 and 7.0±1.89 µmoles of Zoledronate/ml of packed RBCs for human, Swiss and Balb/C murine RBCs, respectively. Engineered RBCs were able to detach human and murine macrophages in vitro, leading to a detachment of 66±8%, 67±8% and 60.5±3.5% for human, Swiss and Balb/C RBCs, respectively. The in vivo efficacy of loaded RBCs was tested in Balb/C mice administering 59 µg/mouse of RBC-encapsulated Zoledronate. By a single administration, depletion of 29.0±16.38% hepatic macrophages and of 67.84±5.48% spleen macrophages was obtained, confirming the ability of encapsulated Zoledronate to deplete macrophages in vivo. In conclusion, RBCs loaded with Zoledronate should be considered a suitable system for targeted delivery to macrophages, both in vitro and in vivo.
format Online
Article
Text
id pubmed-4072741
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40727412014-07-02 Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells Sabatino, Raffaella Antonelli, Antonella Battistelli, Serafina Schwendener, Reto Magnani, Mauro Rossi, Luigia PLoS One Research Article Bisphosphonates, besides being important drugs for the treatment of various bone diseases, could also be used to induce apoptosis in macrophage-like and cancer cells. However, their activity in vivo is limited by a short plasma half-life and rapid uptake within bone. Therefore, several delivery systems have been proposed to modify their pharmacokinetic profile and biodistribution. Among these, red blood cells (RBCs) represent one of the most promising biological carriers. The aim of this study was to select the best performing compound among Clodronate, Pamidronate, Ibandronate and Zoledronate in killing macrophages and to investigate RBCs as innovative carrier system to selectively target bisphosphonates to macrophages. To this end, the encapsulation of the selected bisphosphonates in autologous RBCs as well as the effect on macrophages, both in vitro and in vivo were studied. This work shows that, among the tested bisphosphonates, Zoledronate has proven to be the most active molecule. Human and murine RBCs have been successfully loaded with Zoledronate by a procedure of hypotonic dialysis and isotonic resealing, obtaining a dose-dependent drug entrapment with a maximal loading of 7.96±2.03, 6.95±3.9 and 7.0±1.89 µmoles of Zoledronate/ml of packed RBCs for human, Swiss and Balb/C murine RBCs, respectively. Engineered RBCs were able to detach human and murine macrophages in vitro, leading to a detachment of 66±8%, 67±8% and 60.5±3.5% for human, Swiss and Balb/C RBCs, respectively. The in vivo efficacy of loaded RBCs was tested in Balb/C mice administering 59 µg/mouse of RBC-encapsulated Zoledronate. By a single administration, depletion of 29.0±16.38% hepatic macrophages and of 67.84±5.48% spleen macrophages was obtained, confirming the ability of encapsulated Zoledronate to deplete macrophages in vivo. In conclusion, RBCs loaded with Zoledronate should be considered a suitable system for targeted delivery to macrophages, both in vitro and in vivo. Public Library of Science 2014-06-26 /pmc/articles/PMC4072741/ /pubmed/24968029 http://dx.doi.org/10.1371/journal.pone.0101260 Text en © 2014 Sabatino et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Sabatino, Raffaella
Antonelli, Antonella
Battistelli, Serafina
Schwendener, Reto
Magnani, Mauro
Rossi, Luigia
Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells
title Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells
title_full Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells
title_fullStr Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells
title_full_unstemmed Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells
title_short Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells
title_sort macrophage depletion by free bisphosphonates and zoledronate-loaded red blood cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072741/
https://www.ncbi.nlm.nih.gov/pubmed/24968029
http://dx.doi.org/10.1371/journal.pone.0101260
work_keys_str_mv AT sabatinoraffaella macrophagedepletionbyfreebisphosphonatesandzoledronateloadedredbloodcells
AT antonelliantonella macrophagedepletionbyfreebisphosphonatesandzoledronateloadedredbloodcells
AT battistelliserafina macrophagedepletionbyfreebisphosphonatesandzoledronateloadedredbloodcells
AT schwendenerreto macrophagedepletionbyfreebisphosphonatesandzoledronateloadedredbloodcells
AT magnanimauro macrophagedepletionbyfreebisphosphonatesandzoledronateloadedredbloodcells
AT rossiluigia macrophagedepletionbyfreebisphosphonatesandzoledronateloadedredbloodcells